Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Alendronic acid effervescent - EffRx

Next Previous
X
Search
Drug Profile

Alendronic acid effervescent - EffRx

Alternative Names: Alendronate effervescent; Alendronate sodium; Binosto; Buffered effervescent alendronate; EX-101; Steovess

Latest Information Update: 15 May 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator EffRx
  • Developer Abiogen Pharma; Adcock Ingram Pharmaceuticals; Ahn-Gook Pharmaceutical; Andrus; Ascendancy Healthcare; EffRx; Hikma Pharmaceuticals; Laboratorios Atral; Lacer; Mission Pharmacal
  • Class Antihypercalcaemics; Bisphosphonates; Calcium regulators; Osteoporosis therapies; Small molecules
  • Mechanism of Action Osteoclast inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Osteoporosis

Highest Development Phases

  • Marketed Male osteoporosis; Osteoporosis; Postmenopausal osteoporosis

Most Recent Events

  • 07 May 2024 Alendronic acid effervescent licensed to Pyridam Farma in Indonesia
  • 06 Feb 2024 Alendronic acid effervescent licensed to Lupin in Vietnam and the Philippines
  • 19 Sep 2023 Alendronic acid effervescent licensed to Radius Health in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top